Fig 1: CLEC2D immunoreactivity in exchange villi based on (a) pregnancy type and (b) HIV status.
Fig 2: CLEC2D immunoreactivity in exchange villi. (a) HIV negative, normotensive healthy controls (N−); (b) HIV positive, normotensive (N+); (c) HIV negative, pre-eclamptic (PE−) and (d) HIV positive, pre-eclamptic (PE+).
Fig 3: CLEC2D immunoreactivity based on villi type across all groups.
Fig 4: CLEC2D immunoreactivity in conducting villi based on (a) pregnancy type and (b) HIV status.
Fig 5: CLEC2D immunoreactivity in conducting villi. (a) HIV negative, normotensive healthy controls (N−); (b) HIV positive, normotensive (N+); (c) HIV negative, pre-eclamptic (PE−) and (d) HIV positive, pre-eclamptic (PE+).
Supplier Page from Abcam for Anti-CLEC2D antibody